Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Omnicell, Inc.
  6. Summary
    OMCL   US68213N1090

OMNICELL, INC.

(OMCL)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/08/2021 06/09/2021 06/10/2021 06/11/2021 06/14/2021 Date
140.42(c) 139.01(c) 140.43(c) 139.03(c) 142.98(c) Last
135 261 146 751 161 396 230 138 314 737 Volume
+0.14% -1.00% +1.02% -1.00% +2.84% Change
More quotes
Financials (USD)
Sales 2021 1 101 M - -
Net income 2021 82,3 M - -
Net cash position 2021 123 M - -
P/E ratio 2021 74,9x
Yield 2021 -
Sales 2022 1 243 M - -
Net income 2022 115 M - -
Net cash position 2022 317 M - -
P/E ratio 2022 57,6x
Yield 2022 -
Capitalization 6 175 M 6 175 M -
EV / Sales 2021 5,50x
EV / Sales 2022 4,71x
Nbr of Employees 2 970
Free-Float 80,2%
More Financials
Company
Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in... 
More about the company
Ratings of Omnicell, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about OMNICELL, INC.
06/09OMNICELLá : JPMorgan Starts Omnicell at Neutral With $146 Price Target
MT
05/28OMNICELL, INCá : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/24OMNICELLá : BTIG Starts Omnicell at Buy With $165 Price Target
MT
05/18INSIDER TRENDS : 90-Day Insider Buying Trend at Omnicell Eased Back with Disposi..
MT
05/04OMNICELLá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
04/30OMNICELLá : Berenberg Bank Adjusts Omnicell PT to $168 From $152, Maintains Buy ..
MT
04/30OMNICELLá : to Provide Medication Management Solution to Scripps Health
MT
04/27OMNICELLá : EnlivenHealth Partners With Twilio to Accelerate Launch of Transform..
BU
04/07OMNICELLá : Aultman Health Foundation to Enhance Medication Management with Omni..
BU
04/01OMNICELLá : to Release First Quarter 2021 Financial Results on April 29, 2021
BU
03/22OMNICELLá : Benchmark Adjusts Omnicell's Price Target to $155 From $140, Maintai..
MT
03/11STREET COLOR : Omnicell Reportedly Receives Higher Bid from Baxter; Shares Spike..
MT
03/03OMNICELLá : The Christ Hospital Health Network Selects Omnicell's Central Pharma..
BU
02/24OMNICELLá : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
02/22OMNICELLá : Appoints Christine Mellon as Chief People Officer
BU
More news
News in other languages on OMNICELL, INC.
01/05OMNICELLá : kooperiert im Rahmen der Ausweitung der Omnicell-Systeme im gesamten..
01/05OMNICELLá : s'associe au Guy's and St Thomas' NHS Foundation Trust de Londres po..
01/04Quels ETF choisir pour investir dans les valeurs moyennes ?
2020WALL STREET STOCK EXCHANGE : USA-Les valeurs à suivre à Wall Street (actualisé)
2020EN DIRECT DES MARCHESá : Sanofi, Dassault, Ubisoft, Softbank, Vale, Tesla, Signi..
More news
Analyst Recommendations on OMNICELL, INC.
More recommendations
Chart OMNICELL, INC.
Duration : Period :
Omnicell, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends OMNICELL, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 10
Average target price 153,50 $
Last Close Price 142,98 $
Spread / Highest target 18,9%
Spread / Average Target 7,36%
Spread / Lowest Target -23,1%
EPS Revisions
Managers and Directors
NameTitle
Randall A. Lipps Chairman, President & Chief Executive Officer
Peter J. Kuipers Chief Financial Officer & Executive Vice President
Giri Chodavarapu Chief Information Officer
Bill Wingfield Vice President-North America Service & Operations
Dan S. Johnston Secretary, Chief Legal & Administrative Officer
Sector and Competitors
1st jan.Capitalization (M$)
OMNICELL, INC.19.13%6 175
VEEVA SYSTEMS INC.11.63%46 472
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED-21.83%31 080
CLOVER HEALTH INVESTMENTS, CORP.-12.58%5 983
PRO MEDICUS LIMITED47.34%4 048
SECTRA AB (PUBL)-12.47%2 973